Back to News
Market Impact: 0.05
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Source: globenewswire.com
Healthcare & Biotech
Zealand Pharma announced it will participate in Morgan Stanley's 24th Annual Global Healthcare Conference. The release provides no financial results, clinical updates, guidance changes, or other material operating developments.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
ZEAL0.10
More News
- If You Invest $1,000 a Year in Morgan Stanley (MS) Stock, How Much Dividend Income Could It Generate Over 20 Years?
- Xencor reports phase 1 data for cancer drug XmAb819
- Biotech stocks are surging. How investors can play the new drug innovation boom
- UK immigration crackdown threatens £15 billion care sector
- IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
- Fact vs. fiction: Doctors share whether peptides are safe and effective